Edition:
India

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

1.95EUR
20 Sep 2019
Change (% chg)

€0.14 (+7.98%)
Prev Close
€1.80
Open
€1.84
Day's High
€1.97
Day's Low
€1.80
Volume
131,607
Avg. Vol
58,853
52-wk High
€3.30
52-wk Low
€1.65

Select another date:

Thu, May 2 2019

Photo

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

May 2 British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

Select another date: